Recent & Archived News
August 30, 2018
Bayer Receives FDA Approval for Jivi®, New Hemophilia A Treatment With Step-Wise Prophylaxis Dosing Regimen
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Jivi® (BAY94-9027, antihemophilic factor [recombinant] PEGylated-aucl) for the routine prophylactic treatment...
August 29, 2018
The Climate Corporation Develops New Predictive Seed Placement Technology, Advances Digital Farming Innovation
Today, The Climate Corporation, a subsidiary of Bayer, announced the advancement of a new predictive seed selection and placement technology to pre-commercial testing. This fall, approximately 50...
August 28, 2018
Protect corn yields with a zero tolerance approach to weed control
As cousins in the pigweed family, Palmer amaranth and waterhemp are aggressive, invasive weeds and a threat to corn yields throughout the Midwest. Palmer amaranth can produce up to half a million...
August 27, 2018
Growers Take Center Stage at Bayer 2018 Farm Progress Show Exhibit
Growers and the agronomic and financial experts they depend on will share real-world experience and tips with their fellow farmers during three interactive panels at Bayer's exhibit space #1126...
August 09, 2018
Bayer Appoints Patrick Lockwood-Taylor to Head North American Consumer Health Business
Bayer today announced the appointment of Patrick Lockwood-Taylor as Regional President, Consumer Health, North America, effective August 13, 2018. Patrick is a seasoned leader with more than 25...
July 27, 2018
Bayer Fact Checks Netflix's The Bleeding Edge
Bayer today released a Fact Check of The Bleeding Edge, which premieres on Netflix on July 27, devotes significant time to Essure, the only FDA-approved non-incisional form of permanent birth...
July 26, 2018
Bayer reaffirms safety profile of Essure
Bayer is reminding women with Essure that the safety profile of Essure, the only Food and Drug Administration (FDA)-approved non-incisional form of permanent birth control, remains positive and...
July 20, 2018
Bayer to voluntarily discontinue U.S. sales of Essure at end of 2018 for business reasons
Bayer has made a business decision to voluntarily discontinue sales and distribution of the Essure® System for Permanent Birth Control in the United States after December 31, 2018. This decision...
July 09, 2018
Bayer's Shirell A. Gross Recognized as One of Savoy Magazine's 2018 Most Influential Black Lawyers
Shirell A. Gross, Esq., Vice-President and Head of Law for Bayer Pharmaceuticals, Radiology, has been recognized by Savoy Magazine as one of their 2018 Most Influential Black Lawyers. The full...
June 29, 2018
Bayer Launches 'myMentor' Peer-to-Peer Support Program for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Bayer announced today the launch of myMentor, a U.S. peer-to-peer support program for adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) or chronic thromboembolic pulmonary...
Want even more Bayer news?
Last Updated: September 24, 2018